Randomized Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2831781 in Healthy Japanese and White Participants
Lia Liefaard(Age UK), Daniel JB Marks(Age UK), Ruth M. Tarzi(Hammersmith Hospital), Yi Cui(Kunming University of Science and Technology), Gerben Bouma(Age UK), Naren Srinivasan(Age UK), Eva Hajduk, Annette S. Gross(Emory University), Edoardo Lisi(Age UK), Frans van den Berg(Hammersmith Medicines Research), Eirini Panoilia(Age UK)
Cited by 3
Related Papers
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung Cancer
|JAMA Oncology|2017|603
Martensitic transformation and shape memory effect in ferromagnetic Heusler alloy Ni2FeGa
|Applied Physics Letters|2003|272
The Immune Subtypes and Landscape of Squamous Cell Carcinoma
|Clinical Cancer Research|2019|206
Intratumor partitioning and texture analysis of dynamic contrast‐enhanced (DCE)‐MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy
|Journal of Magnetic Resonance Imaging|2016|171
<i>MiR-125b</i> Expression Affects the Proliferation and Apoptosis of Human Glioma Cells by Targeting <i>Bmf</i>
|Cellular Physiology and Biochemistry|2009|153